Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Brunzell

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Increased ApoB in small dense LDL particles predicts premature coronary artery diseaseJohn D Brunzell
The New England Journal of Medicine|September 7, 2007
Clinical practice. HypertriglyceridemiaJohn D Brunzell
Diabetes Care|December 8, 2005
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Goldberg et alJohn D Brunzell
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease riskMolly C Carr, John D Brunzell
Journal of Clinical Lipidology|September 27, 2012
The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitisJohn D Brunzell, Helmut G Schrott
PPAR Research|April 11, 2009
The role of the PGC1α Gly482Ser polymorphism in weight gain due to intensive diabetes therapySamir S Deeb, John D Brunzell
The American Journal of Cardiology|September 6, 2003
Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemiaAmir F Ayyobi, John D Brunzell
The American Journal of Medicine|December 18, 2003
Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitusJohn D Brunzell, Amir F Ayyobi
Journal of the American Society of Nephrology : JASN|March 11, 2014
HDL in CKD: how good is the "good cholesterol?"Ian H de Boer, John D Brunzell
Circulation|December 6, 2012
The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) studyJonathan Q Purnell, Bernard Zinman, John D Brunzell, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Increased ApoB in small dense LDL particles predicts premature coronary artery diseaseJohn D Brunzell
The New England Journal of Medicine|September 7, 2007
Clinical practice. HypertriglyceridemiaJohn D Brunzell
Diabetes Care|December 8, 2005
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Goldberg et alJohn D Brunzell
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease riskMolly C Carr, John D Brunzell
Journal of Clinical Lipidology|September 27, 2012
The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitisJohn D Brunzell, Helmut G Schrott
PPAR Research|April 11, 2009
The role of the PGC1α Gly482Ser polymorphism in weight gain due to intensive diabetes therapySamir S Deeb, John D Brunzell
The American Journal of Cardiology|September 6, 2003
Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemiaAmir F Ayyobi, John D Brunzell
The American Journal of Medicine|December 18, 2003
Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitusJohn D Brunzell, Amir F Ayyobi
Journal of the American Society of Nephrology : JASN|March 11, 2014
HDL in CKD: how good is the "good cholesterol?"Ian H de Boer, John D Brunzell
Circulation|December 6, 2012
The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) studyJonathan Q Purnell, Bernard Zinman, John D Brunzell, et al.
Pageof 8